Medical Director, Endocrinology

The role

The Medical Director establishes and implements the medical affairs strategy for the Afirma endocrinology franchise. This role involves developing KOL relationships, executing publication strategies, supporting the commercial team, and providing scientific leadership for R&D and clinical trials.

What you will do

• Initiate, cultivate and manage relationships with key global opinion leaders
• Lead the development of Veracyte's publication plan
• Collaborate internally and externally to optimize presentations
• Provide input during product concept, feasibility, development, validation, and launch
• Develop technology differentiators to establish product superiority
• Represent the voice of customer for product design
• Plan and design clinical trials including post-launch validation, clinical utility, and cost effectiveness studies
• Represent Veracyte at scientific and medical professional organizational meetings
• Provide leadership and contributions to the commercial team in marketing, sales, payer relations, and medical policy

Required qualifications

• PhD or MD degree
• At least 13 years of expertise in scientific and medical writing and presentations
• Primary authorship on peer reviewed papers
• Oral presentations at national or international scientific meetings
• Responsibility for development and submission of regulatory documents
• At least 10 years of clinical research experience
• Research Protocol development
• Good Clinical Practice Certification
• Data analytics and basic biostatistics
• Flexibility to travel up to 30% of the time to meet with key physicians, researchers and payers, and attend/present at industry events domestically and internationally
• Excellent communication skills
• Ability to translate complex medical messages into communications understood by target audiences

Benefits

• Competitive compensation and benefits

About the company

Veracyte is a global diagnostics company whose vision is to transform cancer care for patients all over the world. The company delivers cancer tests fueled by genomic and clinical data, bioinformatic and AI capabilities, and an evidence-generation engine.